Study to Assess Pharmacokinetics, Safety, and Tolerability of XC-8
Phase 1
Completed
- Conditions
- Asthma
- Interventions
- Drug: XC8 (histamine glutarimide)Drug: Placebo
- First Posted Date
- 2016-08-29
- Last Posted Date
- 2017-05-18
- Lead Sponsor
- EURRUS Biotech GmbH
- Target Recruit Count
- 32
- Registration Number
- NCT02882217
- Locations
- 🇩🇪
Fraunhofer Institut für Toxikologie und Experimentelle Medizin ITEM, Feodor-Lynen-Str.15, Hannover, Germany
🇦🇹Karl Landsteiner Institut für experimentelle und klinische Pneumologie, Wolkersbergenstraße 1, Wien, Austria
© Copyright 2025. All Rights Reserved by MedPath